IMAX vs MOVING iMAGE TECHNOLOGIES
IMAX and MITQ side by side, both in measuring, analyzing, and controlling instruments; photographic, medical and optical goods; watches and clocks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How IMAX and MITQ compare
IMAX is the larger company, worth 470 times as much as MOVING iMAGE TECHNOLOGIES ($2.6B against $5.6M).
IMAX grew revenue faster over the last twelve months (28.1% versus −3.5% for MOVING iMAGE TECHNOLOGIES).
IMAX keeps more of each dollar of sales as profit, with a net margin of 27.7% compared with −3.5% at MOVING iMAGE TECHNOLOGIES.
IMAX scores higher on the StockData Score (14 against 12 for MOVING iMAGE TECHNOLOGIES), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | IMAX | MITQ |
|---|---|---|
| Size and price | ||
| Market cap | $2.6B | $5.6M |
| Share price | $48.29 | $0.566 |
| Change, 1 year | 34.4% | −22.1% |
| Change, 5 years | 164% | −76.8% |
| Beta (5Y) | 0.70 | 0.49 |
| Employees | 679 | 25 |
| StockData Score | ||
| Total score | 14 (better) | 12 |
| Valuation score | 5 (better) | 3 |
| Growth score | 3 (better) | 1 |
| Performance score | 4 (better) | 3 |
| Health score | 2 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 20.9× | – |
| P/S | 5.5× | 0.3× (better) |
| P/B | 5.4× | 1.2× (better) |
| EV/EBITDA | 12.5× | – |
| P/FCF | 18.1× | – |
| FCF yield | 5.5% | – |
| Fair value | $79.21 | $1.96 |
| Margin of safety | 39.0% | 71.1% (better) |
| Growth | ||
| Revenue growth (TTM) | 28.1% (better) | −3.5% |
| Revenue growth, 5Y average | 24.5% (better) | 19.0% |
| Net income growth (TTM) | 239% | – |
| EPS growth (TTM) | 225% | – |
| Profitability | ||
| Gross margin | 63.5% (better) | 27.1% |
| Operating margin | 26.8% (better) | −3.8% |
| Net margin | 27.7% (better) | −3.5% |
| FCF margin | 30.2% | – |
| Return on equity | 31.9% (better) | −12.3% |
| Return on invested capital | 52.9% | – |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Interest coverage | 17.4× | – |
| Current ratio | – | 1.63 |
| Altman Z-score | 4.34 (better) | 1.33 |
| Piotroski F-score | 7 (better) | 4 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 93.7% | 5.8% |
| Held by insiders | 21.6% | 1.2% |
| Insider net buying, 12 months | −$70.2M | – |
| Short interest, % of float | 15.6% | 0.51% |
Go deeper
- IMAX stock overview
- IMAX income statement
- IMAX valuation and score
- MITQ stock overview
- MITQ income statement
- MITQ valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.